|
Patient demographics of ITT population |
||
| Rosuvastatin (n = 232) |
Atorvastatin (n = 233) |
|
|
|
||
| Gender, male/female (%) |
128/104 (55.2/44.8) |
136/97 (58.4/41.6) |
| Race, white (%) |
229 (98.7) |
229 (98.3) |
| Mean age, years (SD) |
63.5 (8.8) |
65.0 (8.6) |
| Mean weight, kg (SD) |
84.8 (14.3) |
82.5 (13.5) |
| Mean BMI, kg/m2 (SD) |
29.0 (3.6) |
28.4 (3.6) |
| Mean baseline LDL-C, mmol/L (SD) |
4.6 (0.85) |
4.6 (0.82)a |
| Mean baseline HDL-C, mmol/L (SD) |
1.2 (0.27) |
1.2 (0.27)a |
| Mean baseline TG, mmol/L (SD) |
2.0 (1.0) |
2.0 (0.93)a |
|
ITT: Intention to treat, SD: Standard deviation, BMI: Body mass index, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol, TG: Triglycerides an = 232 | ||
Berne et al. Cardiovascular Diabetology 2005 4:7 doi:10.1186/1475-2840-4-7 |
||